It works by targeting two key gut hormones: GLP-1 (glucagon-like peptide-1): Helps regulate appetite by signaling fullness to the brain, slowing down stomach emptying, and managing blood sugar
Serious risks exist and are listed below
What Does the Research Say About Mounjaro
The broader peptide research landscape supports slow titration for improved adherence, and the SURMOUNT-MAINTAIN trial may provide relevant data when it reports results
The SURPASS-CVOT trial results, analyzed in early 2026, showed that a primary cardiorenal endpoint occurred in only 23.7% of patients treated with Tirzepatide compared to 27.4% for those on other therapies over a median of 46.9 months
Talk to your healthcare provider If your tirzepatide headaches are persistent, severe, or getting worse, talk to your healthcare provider